EGFR mutations and molecularly targeted therapy: A new era in the treatment of lung cancer

Jonathan E. Dowell; John D. Minna

doi:10.1038/ncponc0476

EGFR mutations and molecularly targeted therapy: A new era in the treatment of lung cancer

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	170-171
Number of pages	2
Journal	Nature Clinical Practice Oncology
Volume	3
Issue number	4
DOIs	https://doi.org/10.1038/ncponc0476
State	Published - Apr 2006

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/ncponc0476

Cite this

@article{bcf08bffadb349879ce3e85b34ad94cc,

title = "EGFR mutations and molecularly targeted therapy: A new era in the treatment of lung cancer",

author = "Dowell, {Jonathan E.} and Minna, {John D.}",

year = "2006",

month = apr,

doi = "10.1038/ncponc0476",

language = "English (US)",

volume = "3",

pages = "170--171",

journal = "Nature Clinical Practice Oncology",

issn = "1743-4254",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - EGFR mutations and molecularly targeted therapy

T2 - A new era in the treatment of lung cancer

AU - Dowell, Jonathan E.

AU - Minna, John D.

PY - 2006/4

Y1 - 2006/4

UR - http://www.scopus.com/inward/record.url?scp=33645709473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645709473&partnerID=8YFLogxK

U2 - 10.1038/ncponc0476

DO - 10.1038/ncponc0476

M3 - Review article

C2 - 16596125

AN - SCOPUS:33645709473

SN - 1743-4254

VL - 3

SP - 170

EP - 171

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

IS - 4

ER -

EGFR mutations and molecularly targeted therapy: A new era in the treatment of lung cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this